— Know what they know.
Not Investment Advice
Also trades as: 688236.SS (SHH) · $vol 5M

1858.HK HKSE

Beijing Chunlizhengda Medical Instruments Co., Ltd.
1W: -4.0% 1M: -10.1% 3M: -18.2% YTD: -46.6% 1Y: -55.0% 3Y: -45.0% 5Y: -61.6%
HK$7.48 ($0.95)
-0.35 (-4.53%)
 
Weekly Expected Move ±5.2%
HK$7 HK$7 HK$7 HK$8 HK$8
HKSE · Healthcare · Medical - Devices · Tech Score Sell · Power 37 · HK$4.5B mcap · 579M float · 0.129% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 02, 2026
DCF
5
ROE
3
ROA
5
D/E
2
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. 1858.HK receives an overall rating of A. Strongest factors: DCF (5/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (2/5).
Rating Change History
DateFromTo
2026-10-02 A+ A
2026-08-25 A A+
2026-08-13 A- A
2026-08-10 A A-
2026-05-18 A+ A
2026-05-11 A A+
2026-04-30 A- A
2026-04-08 None ADDED
2026-04-07 EXISTED None
2026-03-02 A- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
74
Balance Sheet
94
Earnings Quality
69
Growth
61
Value
—
Momentum
84
Safety
—
Cash Flow
86

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓
Beneish M-Score
-2.46
Unlikely Manipulator
Ohlson O-Score
-12.02
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.8/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.11x
Accruals: -0.8%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. 1858.HK scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. 1858.HK's score of -2.46 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. 1858.HK's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. 1858.HK receives an estimated rating of AA- (score: 82.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). 1858.HK's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
19.76x
PEG
0.28x
P/S
5.59x
P/B
1.78x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$11.39
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 19.8x earnings, 1858.HK trades at a reasonable valuation. Graham's intrinsic value formula yields $11.39 per share, suggesting a potential 52% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.903
NI / EBT
×
Interest Burden
1.012
EBT / EBIT
×
EBIT Margin
0.312
EBIT / Rev
×
Asset Turnover
0.274
Rev / Assets
×
Equity Multiplier
1.189
Assets / Equity
=
ROE
9.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. 1858.HK's ROE of 9.3% is driven by a balanced combination of operating margin, asset efficiency, and leverage. A tax burden ratio of 0.90 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.75%
Fair P/E
10.01x
Intrinsic Value
$7.23
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with 1858.HK's realized 0.8% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. 1858.HK trades at a premium to its adjusted intrinsic value of $7.23, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 10.0x compares to the current market P/E of 19.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$7.48
Median 1Y
$6.51
5th Pctile
$2.41
95th Pctile
$17.53
Ann. Volatility
58.8%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 24.8% 18.2% 18.1% 17.0% 17.0% 11.9% 10.9% 10.4% 10.3% 9.9% 9.7% 8.3% 5.7% 4.4% 4.4% 5.6% 8.8% 9.3% 9.3% 9.3% 9.28%
ROA 18.0% 14.2% 14.3% 13.6% 13.8% 9.6% 9.0% 8.4% 8.6% 7.9% 8.0% 6.5% 4.6% 3.5% 3.6% 4.5% 7.3% 7.6% 7.7% 7.8% 7.80%
ROIC 43.6% 41.2% 36.6% 30.1% 28.4% 28.7% 22.4% 23.7% 21.1% 33.1% 27.0% 28.8% 18.0% 13.2% 11.8% 17.6% 25.1% 33.2% 27.1% 27.8% 27.83%
ROCE 24.1% 13.5% 13.2% 12.2% 11.5% 11.1% 10.0% 9.7% 10.2% 8.9% 8.7% 7.1% 4.9% 3.2% 3.2% 4.7% 7.5% 9.1% 9.3% 9.6% 9.63%
Gross Margin 77.4% 75.2% 80.5% 68.9% 72.0% 79.7% 68.4% 74.7% 67.0% 71.7% 73.8% 65.0% 66.8% 55.2% 66.7% 57.0% 67.6% 60.6% 66.3% 62.7% 62.73%
Operating Margin 21.3% 30.0% 31.6% 24.7% 30.1% 22.1% 22.8% 20.8% 22.9% 26.4% 26.7% 14.5% -13.1% 21.9% 28.1% 24.4% 28.7% 27.5% 29.0% 33.5% 33.50%
Net Margin 20.6% 30.3% 28.8% 26.4% 28.0% 22.2% 22.7% 23.9% 21.7% 23.3% 24.8% 15.1% -13.9% 21.5% 25.3% 21.9% 28.7% 28.0% 28.4% 29.1% 29.10%
EBITDA Margin 22.9% 31.1% 33.2% 26.6% 24.9% 28.1% 25.6% 24.0% 22.8% 23.5% 27.8% 8.8% 1.6% 16.3% 28.5% 24.1% 31.5% 31.1% 35.4% 40.1% 40.09%
FCF Margin -1.0% -3.1% -3.0% -4.1% -3.7% 1.3% -5.4% 5.7% 10.5% 39.6% 38.6% 42.5% 48.6% -6.3% -0.2% 16.6% 12.0% 33.9% 40.6% 25.7% 25.69%
OCF Margin 18.0% 14.9% 11.8% 5.4% 2.6% 3.4% -5.0% 7.1% 10.6% 42.3% 42.4% 46.0% 52.0% -0.2% 6.4% 22.8% 18.2% 39.6% 46.5% 31.6% 31.55%
ROE 3Y Avg snapshot only 7.59%
ROE 5Y Avg snapshot only 9.10%
ROA 3Y Avg snapshot only 6.22%
ROIC 3Y Avg snapshot only 25.47%
ROIC Economic snapshot only 8.49%
Cash ROA snapshot only 8.52%
Cash ROIC snapshot only 33.05%
CROIC snapshot only 26.91%
NOPAT Margin snapshot only 26.57%
Pretax Margin snapshot only 31.57%
R&D / Revenue snapshot only 11.74%
SGA / Revenue snapshot only 21.74%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 19.764
P/S Ratio — — — — — — — — — — — — — — — — — — — — 5.588
P/B Ratio — — — — — — — — — — — — — — — — — — — — 1.784
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.277
Graham Number snapshot only $11.39
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.87 5.57 6.09 5.66 6.25 4.66 5.25 4.34 5.56 4.44 5.63 4.16 4.76 5.20 5.73 5.89 6.33 5.20 6.09 6.55 6.546
Quick Ratio 3.31 5.20 5.71 5.25 5.62 4.23 4.65 3.74 4.71 3.80 4.71 3.43 3.80 4.19 4.60 4.73 5.09 4.28 4.98 5.37 5.373
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.001
Net Debt/Equity -0.48 -0.70 -0.67 -0.62 -0.59 -0.63 -0.58 -0.62 -0.57 -0.73 -0.67 -0.72 -0.69 -0.67 -0.62 -0.69 -0.67 -0.74 -0.69 -0.70 -0.696
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.001
Debt/EBITDA 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 0.009
Net Debt/EBITDA -1.79 -4.82 -4.68 -4.64 -4.62 -5.07 -5.02 -5.50 -5.06 -7.25 -6.81 -8.74 -10.92 -14.91 -13.82 -11.21 -7.66 -7.38 -6.75 -6.44 -6.441
Interest Coverage — — — — — — — — 33358.82 30224.99 29938.68 23361.94 — — — — 122676.88 10637.03 11016.51 2937.82 2937.825
Equity Multiplier 1.33 1.21 1.20 1.21 1.19 1.25 1.22 1.27 1.21 1.27 1.21 1.29 1.25 1.23 1.21 1.20 1.19 1.23 1.19 1.18 1.178
Cash Ratio snapshot only 4.726
Debt Service Coverage snapshot only 3202.183
Cash to Debt snapshot only 694.668
FCF to Debt snapshot only 81.367
Defensive Interval snapshot only 2581.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.62 0.49 0.50 0.50 0.48 0.37 0.37 0.36 0.38 0.34 0.34 0.29 0.27 0.23 0.23 0.26 0.30 0.29 0.29 0.27 0.274
Inventory Turnover 1.36 1.61 1.59 1.65 1.38 1.39 1.35 1.04 0.98 1.02 0.84 0.69 0.55 0.59 0.59 0.67 0.71 0.71 0.69 0.64 0.636
Receivables Turnover 2.70 2.47 2.35 2.49 2.29 1.86 1.70 1.98 1.90 2.00 1.92 2.09 1.88 2.44 1.84 2.65 3.32 4.64 2.74 3.74 3.739
Payables Turnover 2.59 3.15 2.70 2.26 2.38 1.84 2.04 1.46 1.90 1.53 1.60 1.38 1.38 1.28 1.52 1.80 2.09 1.99 2.15 2.33 2.331
DSO 135 148 156 146 159 197 215 184 192 183 190 175 194 150 198 138 110 79 133 98 97.6 days
DIO 269 227 229 222 264 263 270 352 374 359 433 527 662 621 615 544 513 513 526 574 573.9 days
DPO 141 116 135 162 153 198 179 250 192 239 229 265 264 286 240 203 174 183 170 157 156.6 days
Cash Conversion Cycle 263 259 250 206 270 262 306 287 374 302 395 437 592 485 573 479 449 408 489 515 514.9 days
Fixed Asset Turnover snapshot only 2.018
Operating Cycle snapshot only 671.5 days
Cash Velocity snapshot only 0.456
Capital Intensity snapshot only 3.706
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 7.8% 18.2% 13.1% 18.1% 16.9% 8.4% 4.6% -2.2% 7.3% 0.6% -0.6% -10.5% -25.1% -33.3% -31.3% -12.8% 13.9% 29.2% 26.1% 6.1% 6.09%
Net Income 8.9% 13.8% 3.0% 0.5% 14.1% -4.5% -11.7% -14.5% -15.0% -9.7% -4.3% -16.6% -43.2% -55.0% -53.8% -30.5% 61.2% 1.2% 1.1% 72.2% 72.19%
EPS 8.4% 12.8% -9.4% -6.8% 4.6% -15.8% -7.6% -17.9% -17.3% -8.7% -9.6% -9.0% -43.9% -52.3% -53.0% -33.6% 66.2% 1.1% 1.2% 69.4% 69.40%
FCF -1.1% -1.1% -1.1% -1.4% -3.4% 1.5% -88.2% 2.4% 4.0% 28.7% 8.2% 5.7% 2.5% -1.1% -1.0% -66.1% -72.0% 7.9% 259.5% 64.7% 64.66%
EBITDA 5.9% 7.7% -3.3% -8.5% 0.8% -5.5% -12.3% -11.3% -6.4% -15.0% -9.6% -24.3% -44.3% -56.3% -54.8% -22.9% 48.2% 1.4% 1.4% 85.1% 85.07%
Op. Income 5.7% 7.7% -3.7% -9.6% 4.2% -9.1% -17.0% -16.7% -18.1% -9.0% 0.0% -8.0% -35.6% -54.1% -52.8% -29.6% 53.6% 1.2% 1.1% 62.2% 62.16%
OCF Growth snapshot only 46.54%
Asset Growth snapshot only 2.92%
Equity Growth snapshot only 4.81%
Debt Growth snapshot only 11.11%
Shares Change snapshot only 1.65%
Dividend Growth snapshot only 16.71%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 30.4% 30.6% 25.3% 22.0% 14.9% 12.0% 13.0% 9.7% 10.6% 8.8% 5.6% 1.1% -2.0% -10.1% -10.6% -8.6% -2.9% -4.7% -4.8% -6.1% -6.12%
Revenue 5Y 37.3% 39.7% 39.6% 40.2% 34.6% 32.0% 28.1% 24.6% 22.7% 19.4% 15.4% 9.7% 4.1% -1.2% -0.3% 0.6% 2.9% 2.1% 0.4% -0.9% -0.89%
EPS 3Y 44.7% 44.6% 29.2% 21.9% 14.9% 4.9% 7.7% 0.0% -2.1% -4.6% -8.9% -11.4% -21.4% -28.4% -26.8% -20.9% -8.3% -3.4% -2.6% 0.8% 0.75%
EPS 5Y 38.5% 37.8% 35.9% 36.7% 35.3% 31.3% 29.1% 24.0% 21.2% 18.4% 12.5% 6.2% -6.8% -12.9% -11.9% -9.6% -2.7% -3.0% -5.0% -4.8% -4.77%
Net Income 3Y 44.9% 45.0% 34.4% 25.3% 17.8% 9.1% 10.3% 4.2% 1.8% -0.6% -4.5% -10.5% -18.0% -27.1% -26.9% -20.9% -8.0% -4.1% -1.8% -0.1% -0.07%
Net Income 5Y 39.0% 38.4% 39.1% 38.9% 38.0% 35.1% 30.8% 27.2% 24.2% 21.3% 15.5% 7.0% -4.6% -12.0% -9.9% -8.1% -0.7% -0.9% -2.9% -3.0% -3.02%
EBITDA 3Y 45.5% 43.8% 32.6% 21.9% 12.8% 6.8% 7.2% 0.9% -0.0% -4.7% -8.5% -15.0% -19.3% -29.5% -29.0% -19.7% -8.2% -4.0% -0.7% 2.6% 2.59%
EBITDA 5Y 39.7% 38.4% 38.6% 37.2% 34.7% 33.1% 29.1% 26.1% 23.8% 19.0% 13.1% 4.0% -5.6% -14.7% -12.8% -9.7% -3.8% -2.1% -3.7% -2.6% -2.61%
Gross Profit 3Y 37.8% 38.8% 32.8% 27.3% 18.6% 15.9% 15.7% 12.3% 11.8% 7.9% 4.5% -1.2% -4.5% -15.1% -16.9% -15.1% -8.8% -10.4% -9.6% -10.8% -10.77%
Gross Profit 5Y 38.2% 39.6% 40.1% 39.9% 34.9% 33.7% 30.1% 27.9% 26.0% 22.0% 17.7% 11.0% 5.0% -2.4% -2.1% -2.3% -0.1% -0.8% -2.9% -4.0% -3.95%
Op. Income 3Y 46.5% 44.7% 33.0% 21.7% 14.0% 5.4% 5.4% -1.5% -3.4% -3.8% -7.2% -11.5% -18.1% -27.6% -26.8% -18.6% -6.8% -3.3% -0.8% 1.6% 1.62%
Op. Income 5Y 41.1% 39.6% 39.9% 38.2% 36.7% 33.1% 28.6% 25.0% 21.8% 20.1% 14.4% 6.7% -4.8% -13.3% -11.2% -9.2% -2.2% -2.4% -4.9% -4.6% -4.61%
FCF 3Y — — — — — -45.4% — -15.1% -9.3% 26.4% 26.3% 48.1% — — — — — 1.8% — 55.2% 55.20%
FCF 5Y — — — — — -27.6% — -5.3% 12.4% 53.4% 57.7% 64.2% 45.8% — — 6.8% -6.1% 8.3% 12.9% 12.7% 12.67%
OCF 3Y 16.8% 14.9% 10.3% -11.1% -42.7% -43.8% — -29.4% -19.3% 25.2% 18.3% 23.4% 39.6% — -26.9% 48.0% 84.7% 1.2% — 54.1% 54.10%
OCF 5Y 31.0% 20.5% 12.8% -4.7% -18.7% -14.5% — -5.9% 3.4% 36.4% 38.1% 39.4% 24.4% — -22.8% -2.6% -5.1% 9.6% 9.5% 3.6% 3.60%
Assets 3Y 26.5% 54.4% 47.2% 48.2% 37.0% 41.3% 41.0% 39.8% 29.6% 33.3% 32.0% 30.2% 28.5% 4.9% 4.5% 3.9% 4.4% 2.4% 2.2% 1.1% 1.12%
Assets 5Y 25.0% 40.9% 39.3% 39.9% 37.5% 40.0% 36.5% 37.2% 32.8% 35.0% 30.0% 30.7% 23.6% 23.4% 23.5% 22.4% 18.1% 18.9% 18.6% 16.9% 16.86%
Equity 3Y 25.3% 57.8% 54.5% 55.2% 48.1% 50.0% 51.0% 44.0% 37.1% 38.6% 39.5% 31.6% 31.3% 4.5% 4.2% 4.1% 4.4% 3.2% 3.0% 3.8% 3.79%
Book Value 3Y 25.1% 57.3% 48.5% 50.9% 44.4% 44.1% 47.5% 38.1% 31.8% 33.1% 33.1% 30.4% 25.8% 2.6% 4.4% 4.1% 4.0% 4.0% 2.2% 4.6% 4.64%
Dividend 3Y — — — — — — — -31.9% 28.7% 28.4% 27.7% 1.1% 0.6% 10.3% 12.6% 12.4% -28.7% -16.2% 0.5% 6.7% 6.73%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.96 0.97 0.99 0.99 0.96 0.95 0.95 0.92 0.96 0.91 0.86 0.61 0.33 0.02 0.02 0.00 0.03 0.00 0.06 0.20 0.204
Earnings Stability 0.94 0.93 0.95 0.96 0.96 0.88 0.81 0.73 0.72 0.57 0.47 0.14 0.01 0.19 0.18 0.41 0.20 0.26 0.38 0.44 0.438
Margin Stability 0.93 0.92 0.93 0.94 0.95 0.95 0.94 0.94 0.94 0.93 0.94 0.94 0.95 0.93 0.92 0.91 0.93 0.92 0.91 0.90 0.905
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 1 1 0 0 1 1
Earnings Persistence 0.96 0.94 0.99 1.00 0.94 0.98 0.95 0.94 0.94 0.96 0.98 0.93 0.83 0.50 0.50 0.88 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.91 0.87 0.97 0.99 0.87 0.95 0.88 0.84 0.84 0.90 0.96 0.82 0.45 0.24 0.26 0.64 0.53 0.26 0.27 0.47 0.470
ROE Trend -0.01 -0.15 -0.15 -0.14 -0.11 -0.08 -0.11 -0.09 -0.08 -0.03 -0.02 -0.03 -0.06 -0.06 -0.05 -0.04 0.01 0.02 0.02 0.02 0.022
Gross Margin Trend 0.07 0.06 0.06 0.03 0.01 0.01 -0.02 -0.00 -0.01 -0.05 -0.03 -0.05 -0.03 -0.09 -0.10 -0.12 -0.11 -0.05 -0.04 -0.01 -0.009
FCF Margin Trend -0.15 -0.22 -0.18 -0.17 -0.13 -0.10 -0.15 0.01 0.13 0.40 0.43 0.42 0.45 -0.27 -0.17 -0.08 -0.18 0.17 0.21 -0.04 -0.038
Sustainable Growth Rate 24.8% 18.2% 18.1% 15.1% 14.4% 9.9% 9.0% 9.9% 5.9% 5.6% 5.5% 4.0% 0.7% -1.6% -1.5% -0.4% 7.1% 6.0% 3.3% 2.5% 2.48%
Internal Growth Rate 22.0% 16.6% 16.7% 13.7% 13.2% 8.7% 8.0% 8.7% 5.2% 4.7% 4.7% 3.2% 0.6% — — — 6.2% 5.1% 2.8% 2.1% 2.13%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.61 0.51 0.41 0.20 0.09 0.13 -0.20 0.30 0.47 1.84 1.81 2.09 3.04 -0.02 0.41 1.30 0.75 1.52 1.74 1.11 1.107
FCF/OCF -0.06 -0.21 -0.25 -0.77 -1.41 0.39 1.08 0.80 0.98 0.94 0.91 0.93 0.94 26.89 -0.03 0.72 0.66 0.86 0.87 0.81 0.814
FCF/Net Income snapshot only 0.901
OCF/EBITDA snapshot only 0.928
CapEx/Revenue 19.0% 18.0% 14.8% 9.5% 6.4% 2.1% 0.4% 1.4% 0.2% 2.8% 3.9% 3.4% 3.3% 6.1% 6.6% 6.3% 6.2% 5.7% 5.9% 5.9% 5.86%
CapEx/Depreciation snapshot only 1.806
Accruals Ratio 0.07 0.07 0.08 0.11 0.13 0.08 0.11 0.06 0.05 -0.07 -0.06 -0.07 -0.09 0.04 0.02 -0.01 0.02 -0.04 -0.06 -0.01 -0.008
Sloan Accruals snapshot only 0.027
Cash Flow Adequacy snapshot only 1.180
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 2.53%
Dividend/Share $0.00 $0.00 $0.00 $0.10 $0.13 $0.13 $0.13 $0.03 $0.31 $0.31 $0.30 $0.33 $0.35 $0.46 $0.44 $0.45 $0.13 $0.25 $0.46 $0.53 $0.36
Payout Ratio 0.0% 0.0% 0.0% 11.4% 15.3% 16.3% 17.3% 4.8% 43.1% 43.2% 43.3% 52.0% 87.6% 1.4% 1.3% 1.1% 19.9% 36.2% 64.7% 73.2% 73.23%
FCF Payout Ratio — — — — — 3.1% — 19.8% 93.2% 25.1% 26.3% 26.9% 30.8% — — 1.1% 40.3% 27.8% 42.7% 81.3% 81.26%
Total Payout Ratio 0.0% 0.0% 0.0% 11.4% 15.3% 18.6% 19.8% 7.3% 45.7% 43.2% 43.3% 52.0% 87.6% 1.5% 1.4% 1.2% 24.6% 39.1% 67.7% 73.2% 73.24%
Div. Increase Streak — — — 0 0 0 0 0 1 1 1 0 1 1 1 1 0 0 1 1 1
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.87 0.88 0.89 0.91 0.91 0.91 0.92 0.91 0.92 0.91 0.91 0.92 0.90 0.95 0.94 0.91 0.92 0.90 0.90 0.90 0.903
Interest Burden (EBT/EBIT) 1.03 1.07 1.06 1.10 1.16 1.08 1.10 1.11 1.03 1.15 1.15 1.22 1.24 1.43 1.44 1.24 1.19 1.07 1.04 1.01 1.012
EBIT Margin 0.32 0.31 0.30 0.27 0.27 0.26 0.24 0.23 0.24 0.22 0.22 0.20 0.15 0.11 0.12 0.16 0.22 0.27 0.28 0.31 0.312
Asset Turnover 0.62 0.49 0.50 0.50 0.48 0.37 0.37 0.36 0.38 0.34 0.34 0.29 0.27 0.23 0.23 0.26 0.30 0.29 0.29 0.27 0.274
Equity Multiplier 1.38 1.28 1.26 1.25 1.23 1.24 1.21 1.24 1.20 1.26 1.21 1.28 1.23 1.25 1.21 1.24 1.22 1.23 1.20 1.19 1.189
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.83 $0.93 $0.84 $0.86 $0.87 $0.78 $0.78 $0.71 $0.72 $0.71 $0.70 $0.64 $0.40 $0.34 $0.33 $0.43 $0.67 $0.70 $0.72 $0.72 $0.72
Book Value/Share $3.56 $7.09 $6.53 $6.85 $6.93 $6.89 $7.45 $6.96 $7.15 $7.37 $7.44 $7.85 $7.09 $7.65 $7.43 $7.73 $7.81 $7.74 $7.95 $7.97 $7.98
Tangible Book/Share $3.20 $6.71 $6.19 $6.50 $6.56 $6.54 $7.04 $6.57 $6.76 $6.98 $7.07 $7.44 $6.73 $7.31 $7.11 $7.40 $7.49 $7.43 $7.64 $7.67 $7.67
Revenue/Share $2.84 $3.18 $2.92 $3.18 $3.04 $3.04 $3.20 $2.99 $3.17 $3.09 $3.00 $2.92 $2.35 $2.19 $2.10 $2.43 $2.76 $2.70 $2.69 $2.54 $2.55
FCF/Share $-0.03 $-0.10 $-0.09 $-0.13 $-0.11 $0.04 $-0.17 $0.17 $0.33 $1.23 $1.16 $1.24 $1.14 $-0.14 $-0.00 $0.40 $0.33 $0.92 $1.09 $0.65 $0.65
OCF/Share $0.51 $0.47 $0.34 $0.17 $0.08 $0.10 $-0.16 $0.21 $0.34 $1.31 $1.27 $1.34 $1.22 $-0.01 $0.14 $0.55 $0.50 $1.07 $1.25 $0.80 $0.80
Cash/Share $1.73 $4.99 $4.36 $4.25 $4.12 $4.37 $4.29 $4.29 $4.11 $5.37 $4.98 $5.62 $4.87 $5.12 $4.64 $5.31 $5.22 $5.76 $5.50 $5.56 $5.56
EBITDA/Share $0.96 $1.03 $0.93 $0.91 $0.89 $0.86 $0.85 $0.78 $0.81 $0.74 $0.73 $0.64 $0.45 $0.34 $0.34 $0.47 $0.68 $0.78 $0.81 $0.86 $0.86
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01
Net Debt/Share $-1.72 $-4.98 $-4.36 $-4.24 $-4.12 $-4.37 $-4.29 $-4.29 $-4.11 $-5.37 $-4.97 $-5.62 $-4.87 $-5.12 $-4.64 $-5.31 $-5.22 $-5.75 $-5.50 $-5.55 $-5.55
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 7 5 5 4 4 5 2 4 4 4 5 4 3 4 5 5 8 7 7 7 7
Beneish M-Score -1.97 -1.84 -1.71 -2.70 -1.46 -1.64 -1.50 24.10 -2.12 -3.59 -3.29 -3.07 -3.40 -2.18 -2.29 -2.43 -1.85 -3.05 -3.02 -2.46 -2.462
Ohlson O-Score snapshot only -12.015
ROIC (Greenblatt) snapshot only 10.16%
Net-Net WC snapshot only $6.50
EVA snapshot only $164910949.36
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 77.10 77.10 80.00 77.10 77.10 80.25 73.50 80.25 80.00 82.75 82.75 82.75 80.25 73.50 77.10 80.25 82.75 82.75 82.75 82.75 82.750
Credit Grade snapshot only 4
Credit Trend snapshot only 2.500
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms